Home
>
US Stocks
>
Alkermes plc
Alkermes plc
ALKS

Alkermes plc (ALKS)

$30.851.05%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
30.56
Today Low/High
30.48 / 30.85
52 Week Low/High
$15.35 / $29.11
P/E ratio
-74.6958
Market Cap
$4.69B

Company Details

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders, and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio.
Organisation
Alkermes plc
Employees
2.24K
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Alkermes plc (ALKS) share price today?

Can Indians buy Alkermes plc (ALKS) shares?

How can I buy Alkermes plc (ALKS) shares from India?

Can Fractional shares of Alkermes plc (ALKS) be purchased?

What are the documents required to start investing in Alkermes plc (ALKS) stocks?

We are a SEBI registered investement advisor